<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(8)</volume><submitter>Wright J</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The incidence of varicella in Canada has decreased by almost 99% since vaccination was introduced. However, variation in the timing and eligibility of vaccination programs across the country has resulted in some cohorts being under-vaccinated and therefore potentially susceptible to infection.&lt;h4>Methods&lt;/h4>We used nationally representative specimens from the Biobank of Statistics Canada's Canadian Health Measures Survey (CHMS) as well as residual specimens from Ontario collected between 2009-2014 to estimate population immunity across age-groups and geography, and identify any groups at increased risk of varicella infection.&lt;h4>Results&lt;/h4>The weighted proportion of specimens with antibody levels above the threshold of protection was 93.6% (95% CI: 92.4, 95.0). Prote</pubmed_abstract><journal>PloS one</journal><pagination>e0309154</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11332944</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.</pubmed_title><pmcid>PMC11332944</pmcid><pubmed_authors>Crowcroft N</pubmed_authors><pubmed_authors>Hatchette T</pubmed_authors><pubmed_authors>Perez-Iratxeta C</pubmed_authors><pubmed_authors>Severini A</pubmed_authors><pubmed_authors>Gubbay J</pubmed_authors><pubmed_authors>Joh E</pubmed_authors><pubmed_authors>Wilson SE</pubmed_authors><pubmed_authors>Buchan SA</pubmed_authors><pubmed_authors>Ward BJ</pubmed_authors><pubmed_authors>Serhir B</pubmed_authors><pubmed_authors>Wright J</pubmed_authors><pubmed_authors>McLachlan E</pubmed_authors><pubmed_authors>Deeks SL</pubmed_authors><pubmed_authors>Bolotin S</pubmed_authors><pubmed_authors>Hughes SL</pubmed_authors><pubmed_authors>Brisson M</pubmed_authors><pubmed_authors>Osman S</pubmed_authors><pubmed_authors>Halperin SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.</name><description>&lt;h4>Introduction&lt;/h4>The incidence of varicella in Canada has decreased by almost 99% since vaccination was introduced. However, variation in the timing and eligibility of vaccination programs across the country has resulted in some cohorts being under-vaccinated and therefore potentially susceptible to infection.&lt;h4>Methods&lt;/h4>We used nationally representative specimens from the Biobank of Statistics Canada's Canadian Health Measures Survey (CHMS) as well as residual specimens from Ontario collected between 2009-2014 to estimate population immunity across age-groups and geography, and identify any groups at increased risk of varicella infection.&lt;h4>Results&lt;/h4>The weighted proportion of specimens with antibody levels above the threshold of protection was 93.6% (95% CI: 92.4, 95.0). Prote</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-05-18T12:13:35.742Z</modification><creation>2025-05-18T12:13:35.742Z</creation></dates><accession>S-EPMC11332944</accession><cross_references><pubmed>39159217</pubmed><doi>10.1371/journal.pone.0309154</doi></cross_references></HashMap>